BioCentury
ARTICLE | Clinical News

Reparixin: Phase III started

November 5, 2012 8:00 AM UTC

Dompe began a double-blind, international Phase III trial to evaluate reparixin in about 60 patients. The compound has Orphan Drug designation in the U.S. and EU. ...